乳腺癌放疗与心脏毒性效应的关联:叙述性综述
本叙述性综述探讨乳腺癌放疗与心脏毒性效应的关联,指出左乳肿瘤、经典心血管危险因素及辅助蒽环类化疗可能协同增加心脏病风险,现代放疗技术及呼吸控制或可降低辐射诱导心脏病发生,但指南推荐的药物心脏保护策略在常规实践中的可行性仍需进一步研究,且缺乏基于证据的心脏病筛查与监测推荐。
要点
- 左乳肿瘤、经典心血管危险因素及辅助蒽环类化疗可能协同增加乳腺癌患者心脏病风险。
- 呼吸控制及现代放疗技术可能降低辐射诱导心脏病的发生率和严重程度。
- 缺乏基于证据的放疗后心脏病筛查、监测及治疗推荐,需多学科综合管理。
核心结论
- 乳腺癌放疗与心脏毒性效应相关,左乳肿瘤、经典心血管危险因素及辅助蒽环类化疗可能协同增加风险。
- 现代放疗技术及呼吸控制或可降低辐射诱导心脏病发生,但指南推荐的药物心脏保护策略在常规实践中的可行性仍需研究。
- 缺乏基于证据的放疗后心脏病筛查、监测及治疗推荐,多学科综合管理至关重要。
研究设计与样本
- 叙述性综述,检索范围未明确报告。
主要发现
- 左乳肿瘤患者、存在经典心血管危险因素及接受辅助蒽环类化疗时心脏病风险似乎更高,提示协同关联。
- 呼吸控制及现代放疗技术及其可能的进一步优化可能降低辐射诱导心脏病的发生率和严重程度。
- 多个指南已确定若干药物心脏保护策略以减少心脏毒性效应,但其在常规实践中的可行性需进一步研究。
临床怎么用
- 应在癌症治疗前、中、后及时识别和管理心血管危险因素,以降低癌症治疗相关心脏功能障碍风险。
- 对乳腺癌放疗患者,尤其左乳肿瘤、有经典心血管危险因素或接受蒽环类化疗者,需关注心脏毒性风险。
- 采用呼吸控制及现代放疗技术可能有助于减少辐射诱导心脏病。
- 多学科综合管理对优化乳腺癌放疗患者的心脏健康管理至关重要。
局限性
- 缺乏基于证据的放疗后心脏病筛查模式与强度、监测及治疗推荐。
- 药物心脏保护策略在常规实践中的可行性尚需进一步研究确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: To promptly recognize and manage cardiovascular (CV) risk factors before, during, and after cancer treatment, decreasing the risk of cancer therapy-related cardiac dysfunction is crucial. After recent advances in breast cancer treatment, mortality rates from cancer have decreased, and the prevalence of survivors with a potentially higher CV disease risk has increased. Cardiovascular risks might be associated with the multimodal approach, including systemic therapies and breast radiotherapy (RT). OBSERVATIONS: The heart disease risk seems to be higher in patients with tumors in the left breast, when other classic CV risk factors are present, and when adjunctive anthracycline-based chemotherapy is administered, suggesting a synergistic association. Respiratory control as well as modern RT techniques and their possible further refinement may decrease the prevalence and severity of radiation-induced heart disease. Several pharmacological cardioprevention strategies for decreasing cardiac toxic effects have been identified in several guidelines. However, further research is needed to ascertain the feasibility of these strategies in routine practice. CONCLUSIONS AND RELEVANCE: This review found that evidence-based recommendations are lacking on the modalities for and intensity of heart disease screening, surveillance of patients after RT, and treatment of these patients. A multidisciplinary and multimodal approach is crucial to guide optimal management.
引用
- Meattini I, Poortmans PM, Aznar MC, et al. Association of Breast Cancer Irradiation With Cardiac Toxic Effects: A Narrative Review. JAMA Oncol. 2021. PMID: 33662107. doi:10.1001/jamaoncol.2020.7468
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。